SILVER SPRING, MD – Boston Scientific is voluntarily recalling two core wires for its Rotablator Rotational Atherectomy System, according to an alert from the US Food and Drug Administration (FDA) [1] ...

PARIS, France—A novel atherectomy system designed to clear away hard plaque components may improve outcomes in patients with severely calcified coronary lesions compared with historical controls, ...

Calcified femoropopliteal arterial disease remains a major challenge in endovascular therapy. Vessel preparation technologies have emerged to improve ...

Please provide your email address to receive an email when new articles are posted on . Severe coronary artery calcification poses unique challenges to successful PCI. Severe coronary artery ...

Please provide your email address to receive an email when new articles are posted on . In patients with severely calcified coronary lesions, planned rotational atherectomy appears to be a safe ...

November 11, 2011 (San Francisco, California) — Rotational atherectomy prior to the implantation of a drug-eluting stent (DES) failed to have any impact on in-stent late lumen loss in elderly patients ...

The Gibraltar Cardiac Association has presented a rotablator device to the Gibraltar Health Authority for use in heart ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on developing its excimer laser system to treat vascular diseases, announces ...

The FDA today granted PMA approval to the Diamondback 360 Coronary Orbital Atherectomy System (OAS) for the treatment of severely calcified coronary arteries. Cardiovascular Systems, the manufacturer ...

An atherectomy is a minimally invasive procedure to remove plaque buildup from an artery (blood vessel). Removing this plaque allows blood to flow more freely through the artery. An atherectomy treats ...